EmadNaemMD
Endocrinology • Jacksonville, FLDiabetes, Lipid Metabolism
Assistant Professor, Medicine, University of Florida College of Medicine
Dr. Naem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14540 Old Saint Augustine Rd
Ste 2201
Jacksonville, FL 32258Phone+1 904-880-9696Fax+1 904-390-7452
Education & Training
University of Florida College of Medicine JacksonvilleFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011
Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 2002 - 2005
Graduate Hospital PhiladelphiaInternship, Transitional Year, 2001 - 2002
Damascus University Faculty of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2011 - 2027
AZ State Medical License 2005 - 2014
GA State Medical License 2011 - 2012
IL State Medical License 2002 - 2011
PA State Medical License 2001 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Publications & Presentations
PubMed
- 2 citationsThe effect of black seed (Nigella sativa) extract on lipid metabolism in HepG2 cells.Michael J Haas, Emad Naem, Sultan Almdallaleh, Arshag D Mooradian
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 2022-08-01 - 3 citationsThe clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.Fateen Ata, Adeel Ahmad Khan, Zohaib Yousaf, Hassan Choudry, Areej Marwan Mohammed
Medicine. 2022-07-01 - 2 citationsSuccessful use of the sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with renal transplant and diabetes: a case series and literature review.Wajiha Gul, Emad Naem, Safa Elawad, Tarik Elhadd
Cardiovascular Endocrinology & Metabolism. 2021-03-17
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
